A. Isetta

发表

New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.

A. Mortellaro, S. Songia, P. Gnocchi, 1999, Journal of immunology.

Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin

P. Ghezzi, P. Gnocchi, A. Isetta, 1995, Clinical and diagnostic laboratory immunology.

Cholecystokinin octapeptide in rat central nervous system: Immunocytochemical studies using a monoclonal antibody that does not react with CGRP

A. Isetta, G. Dockray, A. Varró, 1987, Neurochemistry International.

Immunodepressive activity of FCE 23762 on humoral and cell-mediated immune responses in normal mice: comparison with doxorubicin

P. Gnocchi, A. Isetta, D. Trizio, 1992, Agents and Actions.

Differential regulation of cytokine production in lipopolysaccharide tolerance in mice

G. Fantuzzi, P. Gnocchi, A. Isetta, 1993, Infection and immunity.

Macrophage Characteristics of a Cell Line Isolated in Vitro from a Moloney Lymphoma

A. Isetta, D. Trizio, A. Fioretti, 1983, Tumori.

MTT colorimetric assay for testing macrophage cytotoxic activity in vitro.

A. Isetta, M. Fornasiero, M. Ferrari, 1990, Journal of immunological methods.

Synthesis and mitogenic activity of new imidazo[2,1-b]thiazoles

A. Isetta, A. Andreani, A. Locatelli, 1991 .

Synthesis and immunosuppressive activity of novel prodigiosin derivatives.

P. Gnocchi, R. D'Alessio, A. Isetta, 2000, Journal of medicinal chemistry.

On the immunodepressive action of adriamycin

M. Soldati, A. Isetta, C. Intini, 1971, Experientia.

Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology

A. Goldhirsch, A. Isetta, G. Sacchetti, 2004, Cancer Chemotherapy and Pharmacology.

Differential Regulation ofCytokine Production in Lipopolysaccharide Tolerance inMice

P. Gnocchi, A. Isetta, M. Sironi, 1993 .

lnterleukin-10 Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor and Interleukin-1β Production in the Brain without Affecting the Activation of the Hypothalamus-Pituitary-Adrenal Axis

P. Ghezzi, M. Goldman, P. Gnocchi, 1995 .

Inhibition of interleukin-2/p55 receptor subunit interaction by complementary peptides.

G. Fassina, G. Cassani, P. Gnocchi, 1995, Archives of biochemistry and biophysics.

Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets.

A. Mantovani, E. Erba, S. Taverna, 1997, Journal of immunology.

Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis.

P. Ghezzi, M. Goldman, P. Gnocchi, 1995, Neuroimmunomodulation.

Immunosuppressive activity of 4'-iodo-4'-deoxy-doxorubicin on humoral and cell mediated immune responses in mice: comparison with doxorubicin.

A. Isetta, D. Trizio, M. Fornasiero, 1990, International journal of immunopharmacology.

Synthesis and immunomodulating activity of condensed N-aryl-2-cyano-3-oxo-3-pyrazolyl-propanamides.

A. Isetta, M. Tibolla, G. Doria, 1991, Farmaco.

Protective effect of chlorpromazine on TNF-mediated hapten-induced irritant reaction.

G. Fantuzzi, P. Ghezzi, B. Echtenacher, 1995, European cytokine network.

FCE 20696, a new synthetic immunomodulator: Immunopharmacological profile

A. Isetta, D. Trizio, M. Fornasiero, 1989, Agents and Actions.

Antigen specific, suppressor cells induced by the immunomodulator FCE 20696 in aged NZB/WF1 mice

A. Isetta, D. Trizio, M. Fornasiero, 1986, Agents and Actions.

Development and applications of a radioimmunoassay (RIA) for the in vitro and in vivo quantification of murine IL-1 beta.

P. Gnocchi, A. Isetta, D. Trizio, 1992, Lymphokine and cytokine research.